🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2017-05-12
Trial ID
NCT03134638
The goal of this project is to characterize the genetic profile of patients...
Status
Recruiting
Location
Centre Hospitalier Annecy Genevois
Start Date
2015-07
Trial ID
NCT02511288
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Pacific Oncololgy & Hematology
Start Date
2009-06
Trial ID
NCT00920855
Treatments Being Tested
Laboratory studies suggest that the study drug may stop cancer cells from g...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2013-04
Trial ID
NCT01764477
Treatments Being Tested
Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Status
Unknown
Location
Hospital Universitario Virgen de la Victoria
Start Date
2021-03-09
Trial ID
NCT05101265
Treatments Being Tested
This retrospective study aims to assess the effectiveness of systemic treat...
Status
Completed
Location
Erasmus MC
Start Date
2022-09-23
Trial ID
NCT06512766
Treatments Being Tested
This is a study to investigate the efficacy and safety of an infusion of IO...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-07-20
Trial ID
NCT05361174
Treatments Being Tested
The purpose of this study is to evaluate treatment persistence with guselku...
Status
Active Not Recruiting
Location
OMI
Start Date
2021-08-25
Trial ID
NCT05049798
Treatments Being Tested
The purpose of this study is to understand the treatment patterns and clini...
Status
Active Not Recruiting
Location
Bristol Myers Squibb
Start Date
2024-11-22
Trial ID
NCT06971185
Treatments Being Tested